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Abstract 
 
Engineering controlled drug release is a biomedical research interest due to its many 
clinical applications including: disease targeting, sustained release, and eliminating the 
need for repeating dosages. For example, in veterinary medicine, there is a need for a 
long-lasting and reversible contraceptive option for large and small animals. A device 
made of electrospun material is proposed to provide longer lasting release of Deslorelin, 
gonadotropin-releasing hormone agonist than current conceptive devices. Engineering 
this capsule-based device requires an understanding of the polymer components, one of 
which will be a layer of electrospun polycaprolactone (PCL). The short-term release of a 
specific fluorescent dye, Rose Bengal, through a single layer of sintered electrospun 
PCL was quantified in two solutions: distilled water and phosphate buffered saline 
(PBS). The results showed that the PBS solution significantly (p=0.0006) impacted the 
release of the dye. PBS induced an average flux of 0.009 ng/mm2-day while the flux in 
solution without PBS was essentially nil. These results prompted further investigation 
and a literature review of available drug release models to create a better understanding 
of the plausible mechanisms of release. The implication of this investigation is that 
diffusion may not be the only significant contributor to the release through these 
capsules, as is often assumed.  	 	
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Introduction 	
A. Significance of Drug Release  
There is a significant need for improved drug eluting devices. Investigations into specific 
forms of such devices comprise a significant component of research within academia 
and industry. This is in part due to the complexities of biology and disease, and in part 
due to the regulatory and economic constraints associated with medical device design. 
First, the importance of drug delivery, and drug targeting is intuitive for: diseases such as 
cancer, localized infection sites, diagnostic imaging, and limiting the biofouling 
responses occurring at device interfaces. With precise control over the drug delivery, 
smaller yet clinically effective amounts of a potentially harmful drug (e.g., many 
chemotherapeutics) can be administered. Drug release is important for ensuring the 
drug’s performance, improving patient compliance, and decreasing patient risk. Second, 
the regulatory pathways to developing a drug eluting mechanism are much simpler, 
faster, and less expensive than those associated with developing novel drugs. This 
allows new treatments to be developed quickly by effective modification of the delivery 
and use of already approved drugs.  
 
Sustained drug release is a particular area of interest, especially for medicine in which 
patient compliance and dosing is important. For example, Figure 1 shows what the 
concentration of repeated regular dosing of a drug may look like, compared to a 
sustained release of the required concentration. There is also a narrow range for the 
concentration required for the drug to be therapeutic, and a level when the concentration 
would become toxic. The ideal sustained drug would allow the concentration of drug to 
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remain constant without peaks and valleys, such as the regular dosing, which can 
fluctuate near toxic levels especially in the case of medication misuse.   
	
Figure 1. Benefits of sustained release vs. regular dosing  
 
There are a variety of medications available, which utilize sustained release 
mechanisms. Oral medications can last for several hours, or be engineered to release at 
a specified time (hours) after consumption. But, there are also a few implantable medical 
devices available, which elute drugs. Probably the most common of these implants are 
used in contraceptive medicine. Implanon, a high efficacy product released in the US in 
2006, is an implantable product available for females, which regulates the reproductive 
system hormonally. The implantable cylindrical device can be used for at most 3 years 
before it needs to be replaced1. The device is made of an ethylene-vinyl acetate layer 
which controls the steady release of etonogestril1.  
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In veterinary sciences, there is an implant available for companion animals, as an 
alternative to irreversible surgeries or permanent treatments available only for young 
animals. Suprelorin, an implant, lasts just 1-2 years. However, there is an interest in 
finding a treatment for animals that will allow for both life-long contraception while still 
allowing the possibility of restoration of fertility 2-4.  
 
B. Research Overview  
By modifying the creation, structure, and layers of nanofiber capsules, it has been 
proposed that an implantable device can be created which will provide continuous 
release of appropriate drug concentrations for longer periods of time than current drug 
eluting implants. This device could specifically be used for the sustained release of 
appropriate levels of gonadotropin-releasing hormone (GnRH) agonist, Deslorelin, in 
companion animals as a long-term contraceptive option. This could offer a potential 
solution to many ethical issues surrounding animal overpopulation. The current research 
goal is to create a device lasting longer than 3 years.  
 
In order to create a novel device with the appropriate effective period, a multi-layered 
approach will be utilized. A layered delivery vehicle will have: one layer (#3 on Figure 2) 
being a highly biomimetic outer layer that will be biodegradable and create minimal 
tissue irritation upon implantation, a second interior layer (#2 on Figure 2) being a 
nanofiber geometry that will allow for the appropriate diffusion rate of the drug, and 
Deslorelin suspended in oil, as the drug payload (#1 on Figure 2). The appropriate 
nanofiber layers, compositions, and release mechanisms are being determined and 
investigated through experimentation. The current method used for manufacturing 
nanofiber polymers, is electrospinning. 
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Figure 2. A layered multifunctional delivery vehicle design. 
 
C. Electrospinning  
Electrospinning is a method of manufacturing micro or nanoscaled diameter polymer 
strands. It can be used to create biomimetic, reproducible, and engineered nanofiber 
matrices (Figure 3). Electrospinning involves a dissolved polymer solution, high voltage 
supply, conductive capillary tube, and typically a conductive collecting surface (Figure 4).  
 
Figure 3. Scanning electron microscope image of electrospun nanofibers. 
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Figure 4. Schematic of an electrospinning setup.  	
The electric current applied to the polymer solution is integral to the electrospinning 
process. When the liquid is in the discharging capillary tube, a charge is induced on the 
surface of the liquid. Mutual charge repulsion and the resulting force opposite the 
surface tension induces the droplet extension (shown below in Figure 5) 5,6.  
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Figure 5. Mutual charge repulsion results in extension of particle surface area. 
 
The extended droplet eventually forms a conical shape known as the Taylor Cone. As 
the force applied from the electrical current surpasses the force of the surface tension, a 
charged fluid is ejected from the tip of the Taylor Cone. The solution evaporates as the 
target polymer left behind elongates further.  Due to the effects of mechanical whipping, 
the charged fiber extends as it moves towards the neutrally or oppositely charged 
collector, where it will settle and collect to form a matrix in its final, fully solidified 
polymeric state5 (Figure 3).  
 
Electrospinning setup parameters impact the resulting nanofiber matrix properties, and 
are advantageous for engineering unique materials. Some basic parameters, which can 
be easily manipulated, are described in Table 1, however, specific values for these 
parameters vary greatly based on the material and the application7. Although there are 
models that describe the overall effects of process conditions on fiber production, 
considerable experimentation is typically required to establish optimized versions of 
these parameters. And it should be noted that these parameters may impact one-
another as they are changed. Electrospinning process such as emulsion spinning and 
	7 
core-shell spinning are additional modifications that can be used to create novel 
materials.  Table	1.	A	tabular	description	of	general	electrospinning	parameters.	
Parameters: Impact at Low: 
Impact at 
Moderate or 
Threshold value: 
Impact at High:  
Collecting Distance 
 At too low of a 
collecting 
distance, the 
solvent may not 
evaporate, 
resulting in non-
uniform polymer 
matrices. 
There is a minimum 
threshold distance 
that allows a clean 
collection of 
polymer strands 
without solvent. 
As this distance 
is increased, it 
has been seen 
that fibers can 
be made thinner. 
As they thin, 
they are more 
likely to break.  
 
Applied Voltage 
At too low of a 
voltage, the 
Taylor Cone will 
not form and will 
result in solution 
dripping. 
There is a minimum 
voltage threshold 
that must be 
overcome for the 
Taylor Cone to 
form.  
Higher voltages 
will continue to 
increase the 
charge repulsion 
of the droplet, 
impacting: fiber 
diameter and 
collection time.  
Even 
higher 
voltages 
can cause 
multiple jet 
streams. 
Collector Shape  
and Motion 
If a collector is 
stationary slow 
or wide shaped, 
the fibers will 
collect in 
random 
orientation.  
Large and narrow 
collectors with a 
high amount of 
surface area can be 
moved, and 
specifically spun, to 
achieve varying 
degrees of fiber 
alignment.  
With high 
speeds and a 
large surface 
area, nearly 
completely 
aligned fibers 
can be 
generated.  
 
Flow Rate 
With slower flow 
rates, thinner 
fibers have been 
made.  
 With faster flow 
rates, thicker 
fibers have been 
made.  
 
Solution Viscosity 
With low solution 
viscosity, 
electrospraying 
(a process of 
generating sub-
micron beads) is 
achieved.  
With moderate 
viscosities, 
electrospinning 
results in thin fibers 
with large beads.  
With high 
enough 
viscosity, smooth 
nanofibers are 
achieved.  
Higher: 
thick 
fibers, or 
an un-
spinnable 
solution 
Polymer 
Concentration 
With low 
concentrations, 
electrospraying 
is achieved. 
With moderate 
concentrations, 
electrospinning 
results in thin fibers 
with large beads. 
With high 
enough 
concentration, 
smooth 
nanofibers are 
achieved. 
 
Polymer molecular 
weight 
With low 
molecular 
weight, 
electrospraying 
is achieved. 
With moderate 
polymer weights, 
electrospinning 
results in thin fibers 
with large beads. 
With high 
polymer 
molecular 
weight, smooth 
nanofibers are 
achieved. 
Higher: 
thick fibers 
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D. Electrospinning Applications and Impact 
Electrospinning has been used successfully in air and water filtration, tissue engineering, 
and regenerative medicine5. Its attention has grown over the past decades in research 
and development. This is largely due to an increased interest in nanotechnology, and the 
great amount of flexibility, high throughput, and low costs electrospinning offers 8. The 
first commercial products based on sub-micron fibers were introduced in the early 1980s 
in the United States by Donaldson Co., Inc 8. And there have been many more moves to 
commercialization since 6,8,9. For example, electrospun materials have been used in a 
number of commercial air filtration applications due to better filter efficiency 8. And since 
2012, it has been shown that electrospun fiber can also be used for effective water 
filtration 10. Several properties of electrospun matrices can account for its success in 
filtration: the matrix structure of interconnected open pores, high permeability for gases, 
and a large surface area per volume ratio 11.  
 
Some specific electrospun materials have also received special interest because they 
have been found to be highly biocompatible9,12,13. The nanofibrous geometry of an 
electrospun matrix is similar to the extracellular matrix that exists in vivo, giving it 
biomimetic properties especially useful for tissue engineering, implant design, and cell 
migration studies12. And additionally, these properties make electrospun materials 
especially promising in the field drug delivery. There have been a variety of approaches 
to creating electrospun drug-eluting materials including: drug adsorption to nanofiber, 
drug carrying nanoparticle adsorption to nanofiber, electrospun blends, and 
electrospinning using a drug core13.  
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E. Sintered Polycaprolactone (PCL) 
One main approach used in this lab to modify nanofibers, has been sintering. Sintering is 
the slow densification of material via diffusion-based minimization of surface area and 
may be used to achieve control of the resulting porosity. For example, Figure 6 shows 
electrospun polycaprolactone (PCL) that has been fully sintered to form a dense PCL 
membrane. 
 
Figure 6. Scanning electron microscope image of fully sintered, electrospun PCL.  
 
Electrospun PCL is a common choice for biomedical applications, and has been used 
repeatedly in electrospinning. This thermoplastic can be easily modified and combined 
with a number of other organic and inorganic polymers. PCL is considered 
biodegradable but degrades slowly so that the byproducts (e.g., caproic acid14) never 
reach lethal concentrations. For these reasons, PCL has been used in a number of drug 
release studies previously15,16. It has been polymerized with: drug throughout the 
material so that it releases this payload as it degrades, or drug and varying ratios of 
other polymers to control its degradation rate. PCL has also been used to create drug-
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carrying matrices and drug-carrying disks, which release via diffusion through the 
polymer.  
 
PCL is hydrophobic, and has a relatively simple backbone (Figure 7). These 
hydrophobic properties complicate PCL’s interactions with aqueous environments, 
especially with fluids in vivo. For example, cell, protein, and enzyme adhesion to 
polymers depends heavily on polymer hydrophobicity, which can impact degradation, 
drug release, and drug metabolism. 
 
Figure 7. Polycaprolactone polymeric backbone. 
 
To better understand how a fully sintered, electrospun layer of the proposed drug-eluting 
device will impact overall drug release, this paper focuses on characterizing the release 
mechanisms of this layer in vitro. A simplified approach may elucidate the major 
impacting factors for release, which will allow a better approach for modeling these 
systems in future studies and predicting the long-term device performance.  
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Materials and Methods 	
A. Sample Preparation 
A PCL electrospinning stock solution of 5 wt% PCL dissolved in 1,1,1,3,3,3-hexoflouro-
2-propanol (HFP) was prepared. 2 g of PCL was added to 38 g of HFP in a 100 mL 
narrow mouth glass beaker and stirred with a stir plate and stir rod at 40°C until 
dissolution occurred. The solution was transferred to a 60cc plastic syringe. The 
collector, a 3 mm diameter 316 stainless steel rod, with a length of 6 cm, was cleaned 
with 70% ethanol. The collector was held in a chuck of a corded electric drill and was set 
to rotate at the slowest drill setting, about 900 rpm. The rod was connected to ground by 
a small folded aluminum foil sheet, which allowed the rod to rotate freely while 
maintaining contact and connecting it to ground. The electrospinning was performed in a 
hood, using a 23 kV power supply, a syringe pump, and a 20 gauge needle tip to deliver 
the polymer solution at a flow rate of 5 mL/h to the collector, 20 cm away. 
Electrospinning was stopped at 12 minutes, when the desired capsule wall thickness of 
500-700 µm was achieved. Thickness was measured on a Keyence Laser Micrometer. 
The resulting capsule thicknesses at the end of electrospinning are listed in Table 2.  
 
Table 2. Thickness of the as-spun PCL nanofiber on the collecting rod. 
Sample Average Nanofiber Thickness (µm) 
1 655 
2 640 
3 663 
4 767 
 
Porosity was decreased by sintering the as-spun sample. For this, all rods with the spun 
samples were placed inside a watertight plastic bag with all its air removed. This was 
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then placed in a water bath at 59°C for 3 hours. Cylindrical capsule samples 
approximately 1.5 cm long were then cut from the metal rod, and each sintered PCL 
sample thickness was recorded as it was removed from the rod. The average resulting 
sintered sample thickness was 143.3 ± 34.3 µm. 
 
B. Sample Loading  
In order to obtain a closed capsule to hold a drug reservoir inside, the cylindrical shaped 
sintered sample had to be sealed in both open areas. For this, one side of the capsule 
was sealed using a heat compression commercial sealer. The commercial sealer did not 
have direct temperature control, only a numeric heat scale. After investigation, it was 
found that the 2.5 setting could be used to seal PCL without adverse damage, so this 
was the setting used for sealing. A 10 mg/mL Rose Bengal stock solution in distilled 
water was made (Figure 8). From this, 20 µL were added to each capsule and the 
remaining open end was sealed using the same method, completely closing the capsule. 
The completed sample was then placed in a 10 mL glass vial with either distilled water 
or 1X phosphate buffered saline (PBS) and placed in an incubator at 37°C. The sample 
size for each condition was set to n = 5. An example of the resulting capsule setup is 
shown in Figure 9.  
	
Figure 8. Rose Bengal molecule. 
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Figure 9. Sample setup example. 
 
C. Release Analysis  
A 100 µL aliquot of the test solution was transferred from each sample to a 96 well plate 
at specific times. A record of sample collection is shown in Appendix 1. The 
concentration of Rose Bengal at each time point was found by measuring the 96 well 
plate in a micro-plate reader (SpectraMax, M5 (Molecular Devices)). The micro-plate 
reader, using the setting of 540 nm excitation wavelength and 575 nm emissions 
wavelength, gave a value of fluorescent reading that was correlated to concentration 
using a pre-made calibration curve for Rose Bengal. In order to analyze the dye release 
over time on each specific media, a calibration curve was made for each one, PBS and 
distilled water. Both calibration curves were made in the range of 0 to 10 µg/mL. 
 
  
Solution 
(PBS or DI water) 
Vial Dye Reservoir of Rose Bengal  
Heat sealed ends  
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Results and Discussion 
 
A. Release Results 
Figure 10 shows the release data for samples in distilled water and PBS, respectively. 
The figure shows the PBS solution elucidated a higher percentage of release over time. 
To investigate this significance, the average flux for each profile was calculated and 
compared.  
 
Figure 10. Percent release of Rose Bengal in 1X PBS solution and DI water. 
 
Figure 11 shows the average flux for each condition calculated from the release data. A 
student’s t-test comparing the calculated average flux of each solution resulted in a p-
value of 0.001. 
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Figure 11. The average flux of Rose Bengal release through PCL. 	
B. Weight Gain Results Comparison 
As verification for the results obtained in the release study, the results of another 
experimental setup are presented here. A weight gain study was conducted to test the 
performance of fully sintered electrospun PCL on a variety of different solution gradients.  
 
The performance measure was capsule weight gain or loss over time. The results are 
shown in Figure 12. The figure shows that the capsule with PBS (inside of a capsule) 
and distilled water (outside of a capsule) had a significant weight gain. The results 
supported the results of this study, because in both studies, there was a detectable flux 
of mass when the PCL layer was between distilled water and PBS. In addition, the 
direction of flux was the same in both studies, as in the study mass flux was toward the 
PBS (indicated by weight gain) in the weight gain study and the dye flux was toward the 
PBS (out of the capsule and into the surrounding solution) in the release study. 
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Figure 12. Weight gain study results. 
 
C. Discussion 
The PBS solution consists of ions, which are used to represent ion concentrations in 
vivo. The PBS solution had a working concentration of 137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4 and 0.02% wt sodium azide. Also, the concentration of Rose Bengal in the 
reservoir was just 0.02 mM, comparatively. The high concentration of ions in solution 
could be impacting: the surface morphology of the PCL capsule, degradation, swelling, 
or wettability of the PCL capsule. In addition, the presence of ions introduces an osmotic 
pressure difference and could potentially be introducing an electronic charge gradient 
between the inside and outside of the capsule.  
 
Surface morphology can be impacted by ions because ions are likely to be adhering to 
the PCL capsule surface as a result of the hydrophobicity of PCL. One published study 
tested release from PCL and poly(acrylic acid) (PAA) blends in PBS and simulated body 
D-H20 
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fluid (SBF)14. The study collected FTIR, SEM, and other surface measurements over a 
period of exposure time14.  The results showed that solutions such as SBF and PBS can 
impact the surface and morphology of PCL composites, which intern may impact 
release. Furthermore, similar investigations of electrospun PCL and poly (D,L-lactic-co-
glycolic) acid (PLGA) scaffolds have related mechanical properties and surface 
characteristics to drug release15. In both of these studies, the release was engineered to 
be degradation controlled, as drug was integrated throughout the polymer14,15. 
 
In contrast, experimental setups here may not be impacted by degradation of the PCL. 
Here, only PCL was used (not a blend), and compared to the time scale required for 
PCL degradation (about 2 years), differences in degradation rates between the two 
solution types may not be a likely cause of the difference in the release results which 
were only over a short time period (about 30 days), but this could be contributing the 
differences seen in the weight gain results (about 200 days)17. To further understand the 
basic potential mechanisms of release, a literature review was conducted to record the 
current modeling and predictive methods used in drug release studies.  
 
D. Literature Review of Drug Release Modeling 
The literature has attributed release from PCL to many different factors which creates 
challenges to predicting its behavior. The driving flux can be simplified into the following 
contributors: diffusion, pressure, electric potential, and temperature differences. These 
can be further rationalized to simplify the problem more. Temperature differences will be 
considered insignificant for the purposes of this investigation because both the device 
and the surrounding solution were maintained at 37°C within an incubator. Any electric 
potential present would be impacted by molecular charges of the solvent and solution 
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ions, and could theoretically be impacted by residual charge on the PCL from the 
electrospinning process. However, the sintering process likely allows any residual 
surface charge build-up to be relaxed. Pressure differences could also arise, due to ions 
in solution or device swelling, contributing to the mass flux.  
 
Diffusion due to the reservoir concentration gradient has been the primary approach to 
modeling release in these experiments in the past. These are: based on Fick’s first law, 
a constitutive equation which describes steady-state diffusion driven flux, (Equation 1); 
where 𝐷 is the binary diffusion coefficient of the dilute solute in the solvent and !"!" is the 
solute concentration gradient:  
(1)     𝐽!"## = −𝐷 ∗  !"!" 
and based on Fick’s second law, a description of the rate of concentration accumulation, 
(Equation 2); where !"!"  is the change in concentration with respect to time. 
(2)     !"!" = 𝐷 ∗ !!!!!! 
From these, a number of equations based on flux by diffusion can be derived.  
One notable equation is the Higuchi model, which predicts Fickian diffusion through a 
layer of ointment with drug placed on the skin surface. The key assumptions for the 
classical model are: the initial concentration, 𝑐!, is much greater than the solute 
solubility, 𝑐!, the drug diffusion in the ointment is the rate limiting step, the skin layer is a 
“perfect sink”, and the ointment does not swell or dissolve during the release 18. The 
result is Equation 3; where 𝑀! is the cumulative amount of solute release per unit 
surface area, 𝐴, at time, 𝑡. 
(3)     !!! = 2𝑐!𝐷𝑐!𝑡 
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This is a simple method for modeling the amount of drug release over time, however, the 
assumptions were also about a simple model, one-dimensional release through a 
homogeneous, thin slab. For one-dimensional release through polymeric slabs, a 
general solution to Fick’s second law may be used. There are a number of general 
solutions, which vary in complexity depending on assumptions about: polymer matrix 
geometry, concentration dependent diffusivity, 𝐷(𝑐), boundary conditions, and matrix 
swelling 18. Under the appropriate assumptions, one-dimensional diffusion analysis can 
also be expanded to uniform shapes such as cylinders and spheres by selecting the 
appropriate coordinate system and boundary systems.  
 
In the past, pressure gradient has also been harnessed to control drug release. In these 
systems, osmotic pressure due to differences in solute concentrations cause a flexible 
reservoir or membrane to expand within a confined volume, creating a pressure that 
then delivers drug through a small orifice19. Examples of some of these devices are 
shown in Figure 13.  In each of these examples, there is: a flexible membrane, 
separating an osmotic pressure gradient, which allows the flux of water to change the 
volume of the drug reservoir, pushing drug out through on orifice (Figure 13-A,B,C) or 
porous walls (Figure 13-D). Equations for modeling this type of drug delivery depend 
greatly upon the pressure gradient created. There are a number of equations derived for 
these systems based on differing geometries. As an example, a simple model is 
described in Equation 4; where !"!"  is the differential volume element of water flowing into 
the osmotic membrane chamber over time19. 
(4)      !!!!" = !"!" ∗ 𝑐! 
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A. Elementary osmotic pressure pump delivery design.  
 
B. Rose Nelson osmotic pressure pump. 
 
C. Higuchi-Leeper osmotic pressure pump design. 
	
D. Controlled porosity osmotic pressure pump design. 
Figure 13. Osmotic pressure pump designs and examples19.  
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In systems of release through porous and nanoporous materials, 𝐷 is often replaced with 𝐷!"", or the effective diffusion coefficient, which takes into account factors such as: the 
volume fraction of space available for diffusion relative to the volume of the porous 
system, pore size, pore interconnectivity, the ratio of solute velocity to solvent velocity 
known as the retardation coefficient, or solute dispersion. And previously, transport 
through matrices has been modeled with varying complexity, from using Darcy’s Law or 
Ritger-Peppas model20, to much more complicated expansions of Fick’s first and second 
laws21.   
 
In many approximations, the beginning (first 60%) of the release profile is modeled 
separately than the long-term release profile, because the beginning of release can 
show a “burst release” profile. This profile has been attributed to: surface concentrations 
of solute, uneven distribution of solute within a polymer, and more. However, this part of 
the release has historically been studied less thoroughly22.   	
Conclusions 
In conclusion, PBS significantly impacts the mechanisms governing release through the 
PCL capsule wall. This conclusion is reached by examining the release results, weight 
gain, an FTIR study, and finally the evidence of the many models predicting drug release 
behavior that specifically harness salt gradients created in vivo. These results are 
relevant to successfully modeling and predicting the long-term release of the proposed 
drug-delivering capsule.  As such, the significant factors contributing to the release must 
be understood. Conversely, with a stronger fundamental understanding of the release 
mechanisms, higher performance devices may be targeted. 
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Future Studies 
  
Eventually, future studies will include the creation of models that predict long-term 
capsule behavior. The information presented here will ultimately aid in determining which 
models and assumptions to choose, by helping to determine the true mechanisms of 
release.  To further simplify the problem, and determine why the PCL is responding to 
exposure to PBS, future studies could investigate the change in the capsule’s 
hydrophobicity over time, using contact angle and a goniometer. This would help to 
determine if a change in hydrophobicity at the surface is occurring, and if it is a change 
across a short or long timescale, therefore, impacting long-term, or only the short-term 
release.  
 
Even though the results presented here support that flux is impacted by PBS regardless 
of which side of the membrane it is exposed to (inside or outside of the capsule), it would 
be valuable to determine the extent of osmotic pressure differences that could cause 
changes in the geometry of membrane, such as swelling which could expand either 
existing pores or polymer-chain spacing and increase the rate of release. This could 
potentially be investigated by comparing high-resolution electron microscopy images of 
capsules after exposure to solutions of varying salinity.  
 
Future investigations will also include continued in vitro and in vivo studies involving 
Deslorelin. The drug can undergo hydrolysis (slowly), so the design of the in vivo studies 
requires the Deslorelin to be suspended in oil. This means that the ultimate device must 
have a solution gradient between the inside and outside of the capsule. Therefore, 
understanding the differences found in the release setup used here, a difference 
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between the inside (distilled water) and outside (PBS) is especially important, since the 
device will ultimately be subject to a solution gradient.  
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